Cochrane · systematic review · CD003217
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
Umapathi, T, Hughes, RAC, Nobile‐Orazio, E, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsMycophenolate mofetil versus placebo for multifocal motor neuropathy
Population: people with multifocal motor neuropathy
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Improvement in GNDS after 12 months1 Mycophenolate mofetil vs placebo | RR 0.54 [0.06, 5.26] | 1 study · 28 participants | Moderate |
Serious adverse events Mycophenolate mofetil vs placebo | no estimate extracted | 1 study · 28 participants | Moderate |